[1] 魏兵,李奇玉,蒋静,等.孟鲁司特治疗及预防2~5岁儿童哮喘的疗效观察[J].中国医药,2011,6(3):280-281. [2] Overton NL, Simpson A, Bowyer P.et al.Genetic susceptibility to severe asthma with fungal sensitization[J].Int J Immunogenet,2017,44(3):93-106. [3] Chiba S, Nakamura Y, Mizuno T.et al.Impact of the genetic variants of GLCCI1 on clinical features of asthmatic patients[J].Clin Respir J,2017,9:1-8. [4] Kim LH, Chang H,Namgoong S.et al,Genetic variants of the gasdermin B gene associated with the development of aspirin-exacerbated respiratory diseases[J].Allergy Asthma Proc, 2017,38(1):4-12. [5] 中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会.儿童支气管哮喘诊断与防治指南(2016年版)[J].中华儿科杂志,2016,54(3):167-181. [6] Powell C, Kolamunnage-Dona R, Lowe J,et al.Magnesium sulphate in acute severe asthma in children (MAGNETIC):a randomised, placebo-controlled trial[J].Lancet Respir Med, 2013,1(4):301-308. [7] 中华医学会儿科分会呼吸学组.白三烯受体拮抗剂在儿童常见呼吸系统疾病中的临床应用专家共识[J].中华实用儿科临床杂志,2016,31(13):973-977. [8] Sanak M, Simon HU, Szczeklik A.Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma.[J].Lancet,1997,350:1599-1600. [9] Sayers I, Barton S , Rorke S.et al.Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma[J].Thorax,2003,58(5):417-424. [10] Van Sambeek R, Stevenson DD, Baldasaro M,et al.5′ Flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirinintolerant asthma phenotype in the United States[J].J Allergy Clin Immunol,2000,106(1):72-76. [11] Zhang YG,Huang HL,Huang JC, et al.The -444A/C polymorphism in the LTC4S Gene and the risk of asthma:a meta-analysis[J].Arch Med Res,2012,43(6):444-450. [12] Amrendra K,Shilpy S,Anurag A, et al.Association of the -1072G/A polymorphism in the LTC4S gene with asthma in an Indian population[J].Int Arch Allergy Immunol,2012,159:271-277. [13] Kang MJ, Kwon JW, Kim J, et al.Polymorphisms of the PTGDR and LTC4S influence responsiveness to leukotriene receptor antagonists in Korean children with asthma[J].Hum Genet,2011,56(4):284-289. [14] 吴永红, 刘春涛, 王可,等.白三烯C4合成酶基因多态性与支气管哮喘患者抗白三烯治疗反应性的关系[J].中华结核和呼吸杂志,2008,31(11):806-810. [15] Sayers I, Sampson AP, Ye S,et al.Promoter polymorphism influences the effect of dexamethasone on transcriptional activation of the LTC4 synthase gene[J].Eur J Hum Genet.2003,11(8):619-622. [16] Asano K, Shiomi T, Hasegawa N,et al.Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT1 antagonist, pranlukast, in Japanese patients with moderate asthma[J].Pharmacogenetics.2002,12(7):565-570. [17] 蔡畅,周美茜,李玉苹,等.支气管哮喘患者白三烯基因多态性与抗白三烯治疗的相关性研究[J].中华结核和呼吸杂志,2011,34(5):362-366. [18] Klotsman M, York TP, Pillai SG, et al.Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast[J]Pharmacogenet Genomics,2007,17(3):189-196.
|